1. Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies. (18th August 2021) Authors: Zuckerman, Autumn D; DeClercq, Josh; Choi, Leena; Cowgill, Nicole; McCarthy, Kate; Lounsbery, Brian; Shah, Rushabh; Kehasse, Amanuel; Thomas, Karen C; Sokos, Louis; Stutsky, Martha; Young, Jennifer; Carter, Jennifer; Lach, Monika; Wise, Kelly; Thomas, Toby T; Ortega, Melissa; Lee, Jinkyu; Lewis, ... Journal: American journal of health-system pharmacy Issue: Volume 78:Number 23(2021) Page Start: 2142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and Tolerability of High Dose Atazanavir–Ritonavir and Lopinavir–Ritonavir in Pregnant Women Living with Human Immunodeficiency Virus. (4th October 2017) Authors: McLaughlin, Milena M; Blackshear, Colleen; Hernandez, Joel; Ivanova, Gergana; Gerzenshtein, Lana; Scarsi, Kimberly Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗